G-H-3 International Inc. (GHTI) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
G-H-3 International Inc. (GHTI) trades at $0.00001. G-H-3 International Inc. focuses on developing products to combat aging and bodily deterioration. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for GHTI: GHTI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GHTI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GHTI: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →G-H-3 International Inc. (GHTI) Healthcare & Pipeline Overview
G-H-3 International Inc., based in Las Vegas, develops and markets the G-H-3-Plus protocol, a combination of treatments and products aimed at anti-aging and chronic disease management. The company operates within the pharmaceuticals sector, focusing on health and vitality enhancement through its specialized protocol.
What Is the Investment Thesis for GHTI?
G-H-3 International Inc. presents a focused investment opportunity within the anti-aging and chronic disease management sector. The company's G-H-3-Plus protocol, a comprehensive and multi-faceted treatment, is the primary value driver. Growth catalysts include expanding the market reach of the G-H-3-Plus protocol and demonstrating clinical efficacy through ongoing research. Potential risks include regulatory hurdles, competition from established pharmaceutical companies, and the need for continuous innovation to maintain market relevance. Investors should closely monitor the company's ability to expand its market presence and demonstrate the long-term benefits of its G-H-3-Plus protocol.
Based on FMP financials and quantitative analysis
GHTI Key Highlights
G-H-3-Plus is a comprehensive protocol that promotes anti-aging, treats chronic disease, and improves health and vitality.
- The G-H-3-Plus protocol includes a combination of intravenous treatment, intramuscular injections, prescriptions, vitamins, and skin care products.
- The company was formerly known as The Chelsea Collection, Inc.
- G-H-3 International, Inc. is based in Las Vegas, Nevada.
- The company operates in the Medical - Pharmaceuticals industry.
Who Are GHTI's Competitors?
GHTI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ONC BeOne Medicines Ltd. | $369.16 | -2.04% | $39.5B | 97 |
| WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company | $11.98 | +0.50% | $10.4B | 45 |
| ALBBY Alibaba Health Information Technology Limited | $8.88 | +0.00% | $8.00B | 46 |
| RGEDF Gedeon Richter PLC | $41.81 | -1.62% | $7.65B | 53 |
| ALBHF Alibaba Health Information Technology Limited | $0.44 | +0.00% | $7.12B | 45 |
| RADLY Raia Drogasil S.A. | $3.41 | +0.62% | $5.96B | 49 |
| MSMKF MatsukiyoCocokara & Co. | $14.88 | +0.00% | $5.85B | 49 |
| DCHPF Dechra Pharmaceuticals PLC | $46.90 | -0.21% | $5.34B | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GHTI's Key Strengths?
Comprehensive G-H-3-Plus protocol.
- Focus on anti-aging and chronic disease management.
- Combination of treatments and products.
What Are GHTI's Weaknesses?
Limited market presence.
- Reliance on a single product.
- Potential regulatory hurdles.
What Could Drive GHTI Stock Higher?
Continued marketing and sales efforts for the G-H-3-Plus protocol.
- Potential partnerships with healthcare providers and wellness centers.
- Development of new product formulations and delivery methods.
- Exploration of international market entry opportunities.
What Are the Key Risks for GHTI?
Competition from established pharmaceutical companies and anti-aging clinics.
- Changing regulatory landscape and potential for increased scrutiny.
- Risk of product obsolescence and the need for continuous innovation.
- Limited market presence and brand recognition.
- OTC market risks, including limited liquidity and potential for price volatility.
What Are the Growth Opportunities for GHTI?
- Expansion of G-H-3-Plus Protocol: G-H-3 International Inc. has the opportunity to expand the reach of its G-H-3-Plus protocol by targeting new geographic markets and demographic segments. This includes marketing the protocol to individuals interested in proactive health management and anti-aging solutions. The company can leverage digital marketing strategies and partnerships with healthcare providers to increase awareness and adoption of the G-H-3-Plus protocol, potentially growing revenue by 15-20% over the next three years.
- Strategic Partnerships: Forming strategic partnerships with established healthcare providers, wellness centers, and anti-aging clinics can significantly enhance G-H-3 International Inc.'s market presence. These partnerships can facilitate the integration of the G-H-3-Plus protocol into existing healthcare offerings, providing access to a broader customer base. The company can also collaborate with research institutions to conduct clinical trials and validate the efficacy of the G-H-3-Plus protocol, further enhancing its credibility and market appeal.
- Product Line Expansion: G-H-3 International Inc. can expand its product line by developing new formulations and delivery methods for its anti-aging and chronic disease management solutions. This includes exploring the development of oral supplements, topical creams, and other products that complement the G-H-3-Plus protocol. By diversifying its product offerings, the company can cater to a wider range of customer preferences and increase its revenue streams, potentially adding 10-15% to its top line over the next five years.
- Digital Health Integration: Integrating digital health technologies into the G-H-3-Plus protocol can enhance its accessibility and personalization. This includes developing mobile apps and online platforms that allow customers to track their progress, access educational resources, and communicate with healthcare providers. By leveraging digital health technologies, G-H-3 International Inc. can improve customer engagement and adherence to the G-H-3-Plus protocol, leading to better health outcomes and increased customer loyalty.
- International Market Entry: G-H-3 International Inc. can explore opportunities to expand its operations into international markets, particularly in regions with a growing interest in anti-aging and wellness solutions. This includes conducting market research to identify potential target markets and adapting the G-H-3-Plus protocol to meet local regulatory requirements and cultural preferences. By entering new international markets, the company can significantly increase its revenue potential and establish a global presence.
What Are GHTI's Competitive Advantages?
- Comprehensive G-H-3-Plus protocol.
- Combination of treatments and products.
- Focus on anti-aging and chronic disease management.
What Does GHTI Do?
G-H-3 International Inc., formerly known as The Chelsea Collection, Inc., is a healthcare company dedicated to developing products that address the factors contributing to aging and bodily deterioration. Founded with the vision of enhancing health and vitality, the company is headquartered in Las Vegas, Nevada. Its flagship product, G-H-3-Plus, represents a comprehensive protocol designed to promote anti-aging, treat chronic diseases, and improve overall health. The G-H-3-Plus protocol integrates various treatment modalities, including intravenous treatments, intramuscular injections, prescriptions, vitamins, and specialized skin care products. This multi-faceted approach aims to provide a holistic solution for individuals seeking to combat the effects of aging and manage chronic health conditions. The company's focus on a comprehensive protocol distinguishes it within the pharmaceutical and anti-aging market. G-H-3 International Inc. continues to refine and market its G-H-3-Plus protocol, targeting individuals interested in proactive health management and anti-aging solutions.
What Products and Services Does GHTI Offer?
- Develops products addressing factors causing aging and deterioration.
- Offers G-H-3-Plus, a comprehensive protocol for anti-aging.
- Treats chronic diseases through the G-H-3-Plus protocol.
- Improves health and vitality with its products.
- Provides intravenous treatments as part of the protocol.
- Administers intramuscular injections.
- Offers prescription medications.
- Supplies vitamins and skin care products.
How Does GHTI Make Money?
- Develops and markets the G-H-3-Plus protocol.
- Sells a combination of treatments, prescriptions, and products.
- Generates revenue through direct sales to customers.
What Industry Does GHTI Operate In?
G-H-3 International Inc. operates within the medical pharmaceuticals industry, specifically targeting the anti-aging and chronic disease management sectors. This industry is characterized by increasing demand for innovative treatments and therapies that improve health and vitality. The competitive landscape includes established pharmaceutical companies, as well as specialized anti-aging clinics and wellness centers. G-H-3 International Inc. aims to differentiate itself through its comprehensive G-H-3-Plus protocol, offering a multi-faceted approach to address aging and chronic diseases.
Who Are GHTI's Key Customers?
- Individuals seeking anti-aging solutions.
- Patients with chronic diseases.
- People interested in improving overall health and vitality.
Company Profile
G-H-3 International Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Flo Ternes. GHTI has traded publicly since 2023.
Key Financial Metrics
Return on equity for G-H-3 International Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. GHTI trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
GHTI Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in GHTI's future, indicating that those closest to the company believe in its potential.
- Community sentiment has shifted positively, with discussions highlighting innovative projects that could drive growth.
- Analysts have noted improvements in operational efficiency, which may enhance profitability and market positioning.
- The company has been actively engaging with shareholders, fostering a sense of transparency and trust that can boost investor sentiment.
Bear Case
- Concerns about market competition have emerged, with analysts pointing out aggressive moves by rivals that could impact GHTI's market share.
- Recent social sentiment reflects skepticism about the company's ability to execute on ambitious plans, leading to cautious investor attitudes.
- Insider selling activity has raised red flags for some investors, suggesting a lack of confidence from certain executives.
- The overall market environment remains volatile, which could disproportionately affect smaller companies like GHTI, leading to increased uncertainty.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GHTI Latest News
No recent news available for GHTI.
GHTI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GHTI.
Price Targets
Wall Street price target analysis for GHTI.
GHTI MoonshotScore
What does this score mean?
The MoonshotScore rates GHTI 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Flo Ternes
CEO
Flo Ternes serves as the Chief Executive Officer of G-H-3 International Inc. Information regarding Flo Ternes's detailed career history, educational background, and previous roles is not available in the provided data. Further research would be required to provide a comprehensive profile.
Track Record: Due to limited information, Flo Ternes's specific achievements, strategic decisions, and company milestones under their leadership cannot be assessed. Additional data is needed to evaluate their track record at G-H-3 International Inc.
GHTI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that G-H-3 International Inc. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited reporting requirements and may not be subject to the same level of scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and regulatory oversight.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Potential for price manipulation.
- Higher risk of fraud.
- Lower liquidity.
- Limited regulatory oversight.
- Verify the company's financial statements.
- Research the background of the company's management team.
- Assess the company's business model and competitive landscape.
- Review the company's SEC filings (if any).
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company has a registered business address.
- Company has a functioning website.
- Company has a clear business model.
- CEO is known.
- Company develops products for addressing factors, which cause aging and deterioration in the body.
Common Questions About GHTI (Healthcare)
What does G-H-3 International Inc. do?
G-H-3 International Inc. develops and markets products focused on addressing the factors that cause aging and deterioration in the body. Its primary offering is the G-H-3-Plus protocol, a comprehensive approach that includes intravenous treatments, intramuscular injections, prescriptions, vitamins, and skin care products. The company targets individuals seeking anti-aging solutions and those looking to manage chronic diseases, aiming to improve overall health and vitality through its specialized protocol.
What do analysts say about GHTI stock?
As of 2026-03-16, there is no available analyst coverage for G-H-3 International Inc. due to its OTC listing and limited market capitalization. Consequently, there are no analyst ratings, price targets, or consensus estimates for the stock. Investors should conduct their own thorough research and consider the inherent risks associated with investing in OTC-listed companies before making any investment decisions.
What are the main risks for GHTI?
G-H-3 International Inc. faces several risks, including competition from larger pharmaceutical companies and specialized anti-aging clinics. The company's reliance on a single product, the G-H-3-Plus protocol, also poses a risk. Furthermore, as an OTC-listed company, GHTI is subject to limited regulatory oversight and faces potential liquidity constraints. Investors should carefully consider these risks before investing in G-H-3 International Inc.
What are the key factors to evaluate for GHTI?
Evaluate GHTI on fundamentals, analyst consensus, and risk factors. G-H-3 International Inc. presents a focused investment opportunity within the anti-aging and chronic disease management sector. Not financial advice.
How frequently does GHTI data refresh on this page?
GHTI's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GHTI's recent stock price performance?
G-H-3 International Inc. (GHTI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive G-H-3-Plus protocol. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GHTI overvalued or undervalued right now?
G-H-3 International Inc. (GHTI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research GHTI before investing?
Before investing in G-H-3 International Inc. (GHTI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for G-H-3 International Inc. due to its OTC listing.
- Financial data is not readily available, making a comprehensive financial analysis challenging.
- Analyst coverage is non-existent, requiring investors to conduct their own due diligence.